PROSPECTIVE PHASE II CLINICAL TRIAL OF CARFILZOMIB, RITUXIMAB AND DEXAMETHASONE (CARD) IN WALDENSTROM'S MACROGLOBULINEMIA (WM).

150

  • Treon, S.
  • Tripsas, C.
  • Sheehy, P.
  • Cropper, S.
  • Mostyn, P.
  • Warren, D.
  • Patterson, C.
  • Yang, G.
  • Hunter, Z.
  • Kunsman, J.
  • Ghobrial, I.

  • 1Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, USA

    2Medical Oncology, Dana Farber Cancer Institute, Boston, USA

Hematological Oncology 31:p 146, June 2013.
Copyright © 2013 John Wiley & Sons, Inc.
View full text|Download PDF